Crescita Therapeutics Inc.
CRRTF
Price:
$0.449
Market Cap:
$11.28M
Crescita Therapeutics Inc., a dermatology company, provides non-prescription skincare products and prescription drug products in Canada, the United States, and internationally. The company operates through three segments: Commercial Skincare, Licensing and Royalties, and Manufacturing and Services. It owns proprietary platform technologies, including MMPE and DuraPeel for the development of topicals containing cannabis and hemp. The company's prescription products include Pliaglis, a topical local anesthetic cream that provides dermal analgesia on intact skin prior to superficial dermatological procedures; CTX-101, a Phase III topical formulation utilizing a corticosteroid in combination wit...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2016-04-11
Stock Exchange
PNK
Ticker
CRRTF
PE Ratio
[-4.49]
ROE
[-15.60%]
Current Ratio
[2.70]
Dividend Yield
[0%]
Enterprise Value
[3.77M]
Dividend History
The ROE as of December 2024 (TTM) for Crescita Therapeutics Inc. (CRRTF) is -15.60%
According to Crescita Therapeutics Inc.’s latest financial reports and current stock price. The company's current ROE is -15.60%. This represents a change of 287.90% compared to the average of -4.02% of the last 4 quarters.
Crescita Therapeutics Inc. (CRRTF) Historical ROE (quarterly & annually)
How has CRRTF ROE performed in the past?
The mean historical ROE of Crescita Therapeutics Inc. over the last ten years is 102.04%. The current -15.60% ROE has changed -115.28% with respect to the historical average. Over the past ten years (40 quarters), CRRTF's ROE was at its highest in in the December 2015 quarter at 130.87%. The ROE was at its lowest in in the December 2017 quarter at -63.00%.
Average
102.04%
Median
2.13%
Minimum
-87.46%
Maximum
694.95%
Crescita Therapeutics Inc. (CRRTF) ROE by Quarter and Year
Discovering the peaks and valleys of Crescita Therapeutics Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 56.85%
Maximum Annual ROE = 694.95%
Minimum Annual Increase = -3174.80%
Minimum Annual ROE = -87.46%
| Year | ROE | Change |
|---|---|---|
| 2023 | -10.55% | -358.23% |
| 2022 | 4.09% | -175.90% |
| 2021 | -5.38% | -3174.80% |
| 2020 | 0.18% | -98.01% |
| 2019 | 8.79% | -30.29% |
| 2018 | 12.61% | -114.41% |
| 2017 | -87.46% | 56.85% |
| 2016 | -55.76% | -112.15% |
| 2015 | 458.94% | -33.96% |
Crescita Therapeutics Inc. (CRRTF) Average ROE
How has CRRTF ROE performed in the past?
The current ROE of Crescita Therapeutics Inc. (CRRTF) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages
3-year avg
-3.95%
5-year avg
-0.58%
10-year avg
102.04%
Crescita Therapeutics Inc. (CRRTF) ROE vs. Peers
How is CRRTF’s ROE compared to its peers?
Crescita Therapeutics Inc.’s ROE is less than Amexdrug Corporation (4.42%), greater than The BC Bud Corporation (-383.06%), less than Aspen Pharmacare Holdings Limited (9.48%), greater than Antisense Therapeutics Limited (-73.14%), less than Cipher Pharmaceuticals Inc. (17.93%), less than Cannara Biotech Inc. (7.78%), greater than Knight Therapeutics Inc. (-4.04%), greater than Lowell Farms Inc. (-258.58%), less than Canntab Therapeutics Limited (0%), less than Bionoid Pharma Inc. (33.29%), greater than HLS Therapeutics Inc. (-25.45%), less than CENTR Brands Corp. (237.06%), greater than RAMM Pharma Corp. (-32.53%), greater than Craftport Cannabis Corp. (-194.22%), greater than Speakeasy Cannabis Club Ltd. (-16.76%), less than City View Green Holdings Inc. (51.86%), greater than RavenQuest BioMed Inc. (-203.42%),
| Company | ROE | Market cap |
|---|---|---|
| 4.42% | $338.82K | |
| -383.06% | $4.81M | |
| 9.48% | $5.44B | |
| -73.14% | $19.64M | |
| 17.93% | $258.20M | |
| 7.78% | $49.51M | |
| -4.04% | $362.06M | |
| -258.58% | $326.69K | |
| 0% | $147.02K | |
| 33.29% | $10.19M | |
| -25.45% | $79.80M | |
| 237.06% | $622.99K | |
| -32.53% | $15.16M | |
| -194.22% | $6.27B | |
| -16.76% | $1.31K | |
| 51.86% | $730.24K | |
| -203.42% | $482.11K |
Build a custom stock screener for Crescita Therapeutics Inc. (CRRTF) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Crescita Therapeutics Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Crescita Therapeutics Inc. (CRRTF) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Crescita Therapeutics Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is Crescita Therapeutics Inc.'s ROE?
How is the ROE calculated for Crescita Therapeutics Inc. (CRRTF)?
What is the highest ROE for Crescita Therapeutics Inc. (CRRTF)?
What is the 3-year average ROE for Crescita Therapeutics Inc. (CRRTF)?
What is the 5-year average ROE for Crescita Therapeutics Inc. (CRRTF)?
How does the current ROE for Crescita Therapeutics Inc. (CRRTF) compare to its historical average?